Asia’s ‘Arc of Innovation’: a podcast preview of BioCentury’s East-West Summit 

Evolving biotech ecosystems, trends in deals and science, and highlights of the March 4-6 conference

Asia’s emerging “Arc of Innovation” spans from China, Japan and South Korea through the turf-neutral gateway of Singapore and west to India, with the ecosystems of these countries contributing to the arsenal of therapeutics and diagnostics that benefit patients globally.

On a special edition of the BioCentury This Week podcast, Aslan’s Carl Firth, McKinsey’s Franck Le Deu and Wendy Pan of BayHelix and Goodwin join BioCentury on the eve of next week’s BioCentury-BayHelix East-West Biopharma Summit in Singapore to discuss innovation across Asia, rising East-West deal flow and the opportunities and challenges faced by the region’s various biotech ecosystems. They also detail highlights among the speakers, panels and fireside chats of the three-day event.

Firth is CEO of Aslan Pharmaceuticals Ltd. (NASDAQ:ASLN), an immunology company with roots in Singapore and offices in the U.S. and Asia. Pan is the chair of BayHelix and a partner at Goodwin, where she leads the Asia life sciences practice. Le Deu is a senior partner at McKinsey & Co., where he co-leads the firm’s Asia healthcare practice.

Join BioCentury, BayHelix and McKinsey March 4-6 in Singapore or virtually for the third East-West Biopharma Summit. Two prominent investors in the country’s biotech ecosystem recently joined Editor in Chief Simone Fishburn on The BioCentury Show: ClavystBio’s Khoo Shih and Polaris Partners’ Amy Schulman. Both episodes are available on BioCentury’s YouTube channel.